Adequacy evaluation of fine-needle aspiration biopsy in the breast health clinic setting

Cancer

Volumn 102, Issue 5, 2004, Pages 295-301

  Howell, Lydia P ^a   Gandour Edwards, Regina ^a   Folkins, Katherine ^a   Davis, Robin ^a   Yasmeen, Shagufta ^b   Afify, Alaa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adequacy evaluation; Breast core biopsy; Breast cytology; Breast fine needle aspiration biopsy; Unsatisfactory rate

Indexed keywords

ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CELL; BREAST EPITHELIUM; CANCER CENTER; COMPARATIVE STUDY; CYTOPATHOLOGY; DIAGNOSTIC IMAGING; HUMAN; HUMAN TISSUE; PATHOLOGIST; PRIORITY JOURNAL; TISSUE SECTION;

AMBULATORY CARE FACILITIES; BIOPSY, FINE-NEEDLE; BREAST DISEASES; FALSE NEGATIVE REACTIONS; FEMALE; HUMANS; PATHOLOGY, SURGICAL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY;

EID: 5644246268     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/cncr.20497     Document Type: Article

References (21)

1. Stanley MW, Abele J, Kline T, Silverman JF, Skoog L. What constitutes adequate sampling of palpable breast lesions that appear benign by clinical and mammographic criteria? Diagn Cytopathol. 1995;12:473-482.
2. Moriarty AT. Fine needle biopsy of the breast: when is enough enough? Diagn Cytopathol. 1995;13:373-374.
3. Kline TS. Adequacy and aspirates from the breasts: a philosophical approach. Diagn Cytopathol. 1995;13:470-472.
4. Sneige N. Should specimen adequacy be determined by the opinion of the aspirator or by the cells on the slides? Cancer (Cancer Cytopathol). 1996;81:3-5.
5. Abati A, Abele J, Bacus S, et al. The uniform approach to breast fine-needle aspiration biopsy. Diagn Cytopathol. 1997;16:295-311.
6. Layfield LJ, Mooney EE, Glasgow B, Hirshowitz S, Coogan A. What constitutes an adequate smear in fine needle aspiration cytology of the breast? Cancer (Cancer Cytopathol). 1997;81:16-21.
7. Schmidt WA, Pommier RF, Vetto JT. Sampling adequacy in breast fine-needle aspiration biopsy. Am J Clin Pathol. 1997;108:1-3.
8. Abele J, Stanley MW, Rollins SD, Miller TR. What constitutes an adequate smear in fine needle aspiration cytology of the breast? Cancer (Cancer Cytopathol). 1998;84:57-80.
9. Abele JS, Wagner LT, Miller TR. FNA of breast: cell counts as an illusion of adequacy. A clinical cytopathologists point of view. Cancer (Cancer Cytopathol). 1998;84:319-323.
10. Eckert R, Howell LP. Number, size, and composition of cell clusters as related to breast FNA adequacy. Diagn Cytopathol. 1999;21:105-111.
11. Abati A. To count or not to count? A review of the issue of adequacy in breast FNA. Diagn Cytopathol. 1999;21:142-147.
12. Gail MH, Barinton LA, Byar DP, et al. Projecting individualized probability of developing breast cancer for white females who are being examined annually. J Natl Cancer Inst. 1989;81:1879-1886.
13. Spiegelman D, Colditz GA, Hunter D, et al. Validation of the Gail et al model for predicting individual breast cancer risk. J Natl Cancer Inst. 1994;86:600-607.
14. Howell LP. Equivocal diagnoses in breast aspiration biopsy cytology: sources of uncertainty and the role of "atypical/indeterminate" terminology. Diagn Cytopathol. 1999;21:217-222.
15. Linsk J, Kreuzer G, Zajicek J. Cytologic diagnosis of mammary tumors from aspirate biopsy smears. II. Studies on 210 fibroadenomas and 210 benign dysplasia. Acta Cytol. 1972;16:130-138.
16. Hitchcock A, Hunt CM, Locker A, et al.. A one year audit of fine needle aspiration cytology for the pre-operative diagnosis of breast disease. Cytopathology. 1991;2:167-176.
17. Padel AF, Coghill SB, Powis SJA. Evidence that the sensitivity is increased and the inadequacy rate decreased when pathologists take aspirates for cytodiagnosis. Cytopathology. 1993;4:161-165.
18. Kocjan G. Evaluation of the cost effectiveness of establishing a fine needle aspiration cytology clinic in a hospital outpatient department. Cytopathology. 1991;2:13-18.
19. Vural G, Hagmar B, Lilleng R. A one-year audit of fine needle aspiration cytology of breast lesions: factors affecting adequacy and a review of delayed carcinoma diagnoses. Acta Cytol. 1995;39:1233-1236.
20. Agarwal T, Patel B, Rajan P, Cunningham DA, Darzi A, Hadjiminias DJ. Core biopsy versus FNAC for palpable breast cancers. Is image guidance necessary? Eur J Cancer. 2003;39:52-56.
21. Florentine BD, Cobb CJ, Frankel K, Greaves T, Martin SE. Core needle biopsy. A useful adjunct to fine-needle aspiration in select patients with palpable breast lesions. Cancer (Cancer Cytopathol). 1997;81:33-39.